Tenet Healthcare (THC) Tops Q1 EPS by 12c; Provides Q2, FY16 Guidance

Go back to Tenet Healthcare (THC) Tops Q1 EPS by 12c; Provides Q2, FY16 Guidance

Tenet Reports Results for the First Quarter Ended March 31, 2016

May 2, 2016 4:16 PM EDT

Generated Adjusted EBITDA of $613 million, a $0.56 loss per share from continuing operations, and, after adjusting for certain items, Adjusted diluted EPS of $0.45 during the first quarter of 2016. Same-hospital patient revenue grew 6.0% in the first quarter, driven by 2.2% growth in adjusted admissions and 3.7% growth in revenue per adjusted admission. Hospital segment Adjusted EBITDA totaled $414 million. Ambulatory segment revenue increased 11.0% on a pro forma same-facility system-wide basis in the first quarter, with cases increasing 8.6% and revenue per case increasing 2.2%. Adjusted EBITDA for the ambulatory segment was $136 million, a 44.7% increase on a pro... More